THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Warren Jackman to Atrial Fibrillation

This is a "connection" page, showing publications Warren Jackman has written about Atrial Fibrillation.
Connection Strength

7.249
  1. Comparison of In Vivo Tissue Temperature Profile and Lesion Geometry for Radiofrequency Ablation With High Power-Short Duration and Moderate Power-Moderate Duration: Effects of Thermal Latency and Contact Force on Lesion Formation. Circ Arrhythm Electrophysiol. 2021 07; 14(7):e009899.
    View in: PubMed
    Score: 0.550
  2. Unravelling the paradoxical effects of ganglia ablation. Circ Arrhythm Electrophysiol. 2014 Aug; 7(4):570-2.
    View in: PubMed
    Score: 0.342
  3. Locations of high contact force during left atrial mapping in atrial fibrillation patients: electrogram amplitude and impedance are poor predictors of electrode-tissue contact force for ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2013 Aug; 6(4):746-53.
    View in: PubMed
    Score: 0.318
  4. Pathophysiologic basis of autonomic ganglionated plexus ablation in patients with atrial fibrillation. Heart Rhythm. 2009 Dec; 6(12 Suppl):S26-34.
    View in: PubMed
    Score: 0.245
  5. Linear left atrial lesions in minimally invasive surgical ablation of persistent atrial fibrillation: techniques for assessing conduction block across surgical lesions. Heart Rhythm. 2009 Dec; 6(12 Suppl):S50-63.
    View in: PubMed
    Score: 0.243
  6. Localization of left atrial ganglionated plexi in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2009 Oct; 20(10):1186-9.
    View in: PubMed
    Score: 0.240
  7. Limitations of esophageal temperature-monitoring to prevent esophageal injury during atrial fibrillation ablation. Circ Arrhythm Electrophysiol. 2008 Aug; 1(3):150-2.
    View in: PubMed
    Score: 0.225
  8. Initial experience using a forward directed, high-intensity focused ultrasound balloon catheter for pulmonary vein antrum isolation in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2007 Feb; 18(2):136-44.
    View in: PubMed
    Score: 0.202
  9. Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions. Heart Rhythm. 2006 Feb; 3(2):201-8.
    View in: PubMed
    Score: 0.190
  10. Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation. J Am Coll Cardiol. 2005 Jun 07; 45(11):1878-86.
    View in: PubMed
    Score: 0.181
  11. Relation between pulmonary vein firing and extent of left atrial-pulmonary vein connection in patients with atrial fibrillation. Circulation. 2004 Mar 30; 109(12):1523-9.
    View in: PubMed
    Score: 0.166
  12. Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. Europace. 2023 07 04; 25(7).
    View in: PubMed
    Score: 0.158
  13. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2023 Mar; 66(2):493-506.
    View in: PubMed
    Score: 0.150
  14. Focal atrial fibrillation: experimental evidence for a pathophysiologic role of the autonomic nervous system. J Cardiovasc Electrophysiol. 2001 May; 12(5):592-9.
    View in: PubMed
    Score: 0.136
  15. Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation. 2000 Nov 28; 102(22):2774-80.
    View in: PubMed
    Score: 0.132
  16. A Lattice-Tip Temperature-Controlled Radiofrequency Ablation Catheter for Wide Thermal Lesions: First-in-Human Experience With Atrial Fibrillation. JACC Clin Electrophysiol. 2020 05; 6(5):507-519.
    View in: PubMed
    Score: 0.126
  17. TREAT AF (Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Atrial Fibrillation): A Randomized Clinical Trial. JACC Clin Electrophysiol. 2020 03; 6(3):282-291.
    View in: PubMed
    Score: 0.125
  18. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018 01 01; 20(1):e1-e160.
    View in: PubMed
    Score: 0.108
  19. 2017?HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. Europace. 2018 01 01; 20(1):157-208.
    View in: PubMed
    Score: 0.108
  20. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. J Interv Card Electrophysiol. 2017 Oct; 50(1):1-55.
    View in: PubMed
    Score: 0.106
  21. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017 10; 14(10):e275-e444.
    View in: PubMed
    Score: 0.104
  22. Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation. J Am Coll Cardiol. 2015 Mar 10; 65(9):867-75.
    View in: PubMed
    Score: 0.089
  23. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation. 2013 May 07; 127(18):1916-26.
    View in: PubMed
    Score: 0.078
  24. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 May 07; 61(18):1935-44.
    View in: PubMed
    Score: 0.078
  25. Extra- and intracellular recordings from the avjunction: discerning the mechanisms for irregular ventricular responses during supraventricular arrhythmias. Acta Cardiol. 2012 Apr; 67(2):221-9.
    View in: PubMed
    Score: 0.073
  26. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol. 2012 Mar; 33(2):171-257.
    View in: PubMed
    Score: 0.072
  27. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012 04; 9(4):632-696.e21.
    View in: PubMed
    Score: 0.072
  28. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012 Apr; 14(4):528-606.
    View in: PubMed
    Score: 0.072
  29. Interactions between atrial electrical remodeling and autonomic remodeling: how to break the vicious cycle. Heart Rhythm. 2012 May; 9(5):804-9.
    View in: PubMed
    Score: 0.071
  30. Epicardial confirmation of conduction block during thoracoscopic surgery for atrial fibrillation--a hybrid surgical-electrophysiological approach. Minim Invasive Ther Allied Technol. 2012 Jul; 21(4):293-301.
    View in: PubMed
    Score: 0.071
  31. Pharmacological prevention and termination of focal atrial fibrillation. Europace. 2012 Mar; 14(3):426-30.
    View in: PubMed
    Score: 0.070
  32. Transesophageal echocardiographic assessment of pulmonary veins and left atrium in patients undergoing atrial fibrillation ablation. Echocardiography. 2011 Aug; 28(7):775-81.
    View in: PubMed
    Score: 0.069
  33. Thoracoscopic video-assisted pulmonary vein antrum isolation, ganglionated plexus ablation, and periprocedural confirmation of ablation lesions: first results of a hybrid surgical-electrophysiological approach for atrial fibrillation. Circ Arrhythm Electrophysiol. 2011 Jun; 4(3):262-70.
    View in: PubMed
    Score: 0.068
  34. Low-level right vagal stimulation: anticholinergic and antiadrenergic effects. J Cardiovasc Electrophysiol. 2011 Oct; 22(10):1147-53.
    View in: PubMed
    Score: 0.068
  35. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011 Mar 15; 123(10):e269-367.
    View in: PubMed
    Score: 0.067
  36. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011 Mar 15; 123(10):1144-50.
    View in: PubMed
    Score: 0.067
  37. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2011 Mar 15; 57(11):1330-7.
    View in: PubMed
    Score: 0.067
  38. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm. 2011 Mar; 8(3):e1-8.
    View in: PubMed
    Score: 0.067
  39. Prevention and reversal of atrial fibrillation inducibility and autonomic remodeling by low-level vagosympathetic nerve stimulation. J Am Coll Cardiol. 2011 Feb 01; 57(5):563-71.
    View in: PubMed
    Score: 0.067
  40. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011 Jan 11; 57(2):223-42.
    View in: PubMed
    Score: 0.066
  41. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm. 2011 Jan; 8(1):157-76.
    View in: PubMed
    Score: 0.066
  42. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011 Jan 04; 123(1):104-23.
    View in: PubMed
    Score: 0.066
  43. Non-pharmacological, non-ablative approaches for the treatment of atrial fibrillation: experimental evidence and potential clinical implications. J Cardiovasc Transl Res. 2011 Feb; 4(1):35-41.
    View in: PubMed
    Score: 0.066
  44. Low-level vagosympathetic nerve stimulation inhibits atrial fibrillation inducibility: direct evidence by neural recordings from intrinsic cardiac ganglia. J Cardiovasc Electrophysiol. 2011 Apr; 22(4):455-63.
    View in: PubMed
    Score: 0.066
  45. Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium "Incubator" Think Tank. Am Heart J. 2010 Oct; 160(4):619-26.
    View in: PubMed
    Score: 0.065
  46. Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank. Am Heart J. 2010 Jan; 159(1):17-24.
    View in: PubMed
    Score: 0.062
  47. The role of ganglionated plexi in apnea-related atrial fibrillation. J Am Coll Cardiol. 2009 Nov 24; 54(22):2075-83.
    View in: PubMed
    Score: 0.062
  48. A new epicardial lesion set for minimal access left atrial maze: the Dallas lesion set. Ann Thorac Surg. 2009 Nov; 88(5):1655-7.
    View in: PubMed
    Score: 0.061
  49. Totally thorascopic surgical ablation of persistent AF and long-standing persistent atrial fibrillation using the "Dallas" lesion set. Heart Rhythm. 2009 Dec; 6(12 Suppl):S64-70.
    View in: PubMed
    Score: 0.061
  50. Autonomic mechanism for initiation of rapid firing from atria and pulmonary veins: evidence by ablation of ganglionated plexi. Cardiovasc Res. 2009 Nov 01; 84(2):245-52.
    View in: PubMed
    Score: 0.060
  51. An acute experimental model demonstrating 2 different forms of sustained atrial tachyarrhythmias. Circ Arrhythm Electrophysiol. 2009 Aug; 2(4):384-92.
    View in: PubMed
    Score: 0.059
  52. Comparison of atrial fibrillation inducibility by electrical stimulation of either the extrinsic or the intrinsic autonomic nervous systems. J Interv Card Electrophysiol. 2009 Jan; 24(1):5-10.
    View in: PubMed
    Score: 0.057
  53. Atrial fibrillation begets atrial fibrillation: autonomic mechanism for atrial electrical remodeling induced by short-term rapid atrial pacing. Circ Arrhythm Electrophysiol. 2008 Aug; 1(3):184-92.
    View in: PubMed
    Score: 0.056
  54. Inducibility of atrial and ventricular arrhythmias along the ligament of marshall: role of autonomic factors. J Cardiovasc Electrophysiol. 2008 Sep; 19(9):955-62.
    View in: PubMed
    Score: 0.055
  55. Autonomic mechanism for complex fractionated atrial electrograms: evidence by fast fourier transform analysis. J Cardiovasc Electrophysiol. 2008 Aug; 19(8):835-42.
    View in: PubMed
    Score: 0.055
  56. Antifibrillatory actions of cisatracurium: an atrial specific M2 receptor antagonist. J Cardiovasc Electrophysiol. 2008 Aug; 19(8):861-8.
    View in: PubMed
    Score: 0.055
  57. An acute model for atrial fibrillation arising from a peripheral atrial site: evidence for primary and secondary triggers. J Cardiovasc Electrophysiol. 2008 May; 19(5):519-27.
    View in: PubMed
    Score: 0.054
  58. Minimally invasive pulmonary vein isolation and partial autonomic denervation for surgical treatment of atrial fibrillation. J Interv Card Electrophysiol. 2007 Dec; 20(3):89-93.
    View in: PubMed
    Score: 0.054
  59. Autonomic mechanism to explain complex fractionated atrial electrograms (CFAE). J Cardiovasc Electrophysiol. 2007 Nov; 18(11):1197-205.
    View in: PubMed
    Score: 0.053
  60. Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fibrillation. J Am Coll Cardiol. 2007 Jul 03; 50(1):61-8.
    View in: PubMed
    Score: 0.052
  61. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace. 2007 Jun; 9(6):335-79.
    View in: PubMed
    Score: 0.052
  62. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2007 Jun; 4(6):816-61.
    View in: PubMed
    Score: 0.052
  63. Gradients of atrial refractoriness and inducibility of atrial fibrillation due to stimulation of ganglionated plexi. J Cardiovasc Electrophysiol. 2007 Jan; 18(1):83-90.
    View in: PubMed
    Score: 0.050
  64. Interactive atrial neural network: Determining the connections between ganglionated plexi. Heart Rhythm. 2007 Jan; 4(1):56-63.
    View in: PubMed
    Score: 0.050
  65. Economic burden and co-morbidities of atrial fibrillation in a privately insured population. Curr Med Res Opin. 2005 Oct; 21(10):1693-9.
    View in: PubMed
    Score: 0.046
  66. Rapid and stable re-entry within the pulmonary vein as a mechanism initiating paroxysmal atrial fibrillation. J Am Coll Cardiol. 2005 Jun 07; 45(11):1871-7.
    View in: PubMed
    Score: 0.045
  67. Saline-irrigated radiofrequency ablation electrode with external cooling. J Cardiovasc Electrophysiol. 2005 Mar; 16(3):323-8.
    View in: PubMed
    Score: 0.044
  68. Pulmonary vein isolation during atrial fibrillation: insight into the mechanism of pulmonary vein firing. J Cardiovasc Electrophysiol. 2003 Mar; 14(3):261-2.
    View in: PubMed
    Score: 0.039
  69. Endovascular stimulation within the left pulmonary artery to induce slowing of heart rate and paroxysmal atrial fibrillation. Cardiovasc Res. 2002 May; 54(2):470-5.
    View in: PubMed
    Score: 0.037
  70. Endovascular neural stimulation via a novel basket electrode catheter: comparison of electrode configurations. J Interv Card Electrophysiol. 2000 Apr; 4(1):219-24.
    View in: PubMed
    Score: 0.032
  71. Ventricular rate control during atrial fibrillation by cardiac parasympathetic nerve stimulation: a transvenous approach. J Am Coll Cardiol. 1999 Dec; 34(7):2043-50.
    View in: PubMed
    Score: 0.031
  72. Critical atrial site for ablation of pacing-induced atrial fibrillation in the normal dog heart. J Cardiovasc Electrophysiol. 1997 Nov; 8(11):1255-65.
    View in: PubMed
    Score: 0.027
  73. Ablation of a left-sided free-wall accessory pathway by percutaneous catheter application of radiofrequency current in a patient with the Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol. 1989 Oct; 12(10):1681-90.
    View in: PubMed
    Score: 0.015
  74. Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation. J Interv Card Electrophysiol. 2005 Aug; 13 Suppl 1:37-42.
    View in: PubMed
    Score: 0.011
  75. Reevaluation of enhanced atrioventricular nodal conduction: evidence to suggest a continuum of normal atrioventricular nodal physiology. Circulation. 1983 Feb; 67(2):441-8.
    View in: PubMed
    Score: 0.010
  76. Transvenous parasympathetic nerve stimulation in the inferior vena cava and atrioventricular conduction. J Cardiovasc Electrophysiol. 2000 Jan; 11(1):64-9.
    View in: PubMed
    Score: 0.008
  77. Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode. Am Heart J. 1982 May; 103(5):789-94.
    View in: PubMed
    Score: 0.002
  78. Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias. Circulation. 1980 Nov; 62(5):996-1010.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES